{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:39:22Z","timestamp":1790375962086,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":468,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["N.DEQ20160334875"],"award-info":[{"award-number":["N.DEQ20160334875"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Association pour la Recherche contre le Cancer","doi-asserted-by":"publisher","award":["N. PJA 20151203507"],"award-info":[{"award-number":["N. PJA 20151203507"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jmoldx.2018.05.012","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T14:37:54Z","timestamp":1530801474000},"page":"677-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing"],"prefix":"10.1016","volume":"20","author":[{"given":"Aur\u00e9lie","family":"Dupuy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lemonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Fataccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Martin-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrielle","family":"Robe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Poullot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa","family":"Moktefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie C.","family":"Rousselet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Traverse-Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Delarue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tournilhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8010-2343","authenticated-orcid":false,"given":"Marie H.","family":"Delfau-Larue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Haioun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Copie-Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Pujals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2018.05.012_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2559.2010.03704.x","article-title":"Pathology and biology of peripheral T-cell lymphomas","volume":"58","author":"de Leval","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib2","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib3","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French Lymphopath Network","volume":"35","author":"Laurent","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib4","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3324\/haematol.2015.126300","article-title":"Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets","volume":"100","author":"de Leval","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","article-title":"Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10","volume":"99","author":"Attygalle","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3324\/haematol.2009.010991","article-title":"The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation","volume":"95","author":"Marafioti","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib8","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/PAS.0b013e31817f123e","article-title":"Peripheral T-cell lymphoma with follicular T-cell markers","volume":"32","author":"Rodriguez-Pinilla","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","article-title":"Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells","volume":"30","author":"Dupuis","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project","volume":"31","author":"Federico","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib11","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1200\/JCO.2012.42.5611","article-title":"Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study","volume":"31","author":"Piccaluga","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib15","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib16","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1073\/pnas.1617929114","article-title":"The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development","volume":"113","author":"Lemonnier","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib17","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13046-016-0362-7","article-title":"The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas","volume":"35","author":"Wang","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MOG.0000000000000050","article-title":"Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma","volume":"30","author":"Grassian","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/path.2913","article-title":"IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours","volume":"224","author":"Amary","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/leu.2016.275","article-title":"Isocitrate dehydrogenase mutations in myeloid malignancies","volume":"31","author":"Medeiros","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib22","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1158\/2159-8290.CD-13-0083","article-title":"Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities","volume":"3","author":"Cairns","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/asheducation-2015.1.579","article-title":"Molecularly targeted therapies for acute myeloid leukemia","volume":"2015","author":"Stein","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.beha.2015.10.016","article-title":"IDH2 inhibition in AML: finally progress?","volume":"28","author":"Stein","year":"2015","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1182\/blood-2017-04-779405","article-title":"Enasidenib in mutant-IDH2 relapsed or refractory acute myeloid leukemia","volume":"130","author":"Stein","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib26","first-page":"373","article-title":"Targeting isocitrate dehydrogenase (IDH) in cancer","volume":"21","author":"Fujii","year":"2016","journal-title":"Discov Med"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/annonc\/mdw013","article-title":"IDH mutations in cancer and progress toward development of targeted therapeutics","volume":"27","author":"Dang","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm.3788","article-title":"Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia","volume":"21","author":"Chan","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1084\/jem.20150736","article-title":"Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia","volume":"213","author":"Boutzen","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib30","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.1002\/ajh.23965","article-title":"Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia","volume":"90","author":"Emadi","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib31","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, ed 4, revised","first-page":"585","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib32","doi-asserted-by":"crossref","first-page":"e109714","DOI":"10.1371\/journal.pone.0109714","article-title":"Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR","volume":"9","author":"Nakamoto-Matsubara","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/2051-5960-2-58","article-title":"A new sensitive PCR assay for one-step detection of 12 IDH1\/2 mutations in glioma","volume":"2","author":"Catteau","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib34","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib35","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib36","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11060-013-1056-z","article-title":"Interlaboratory comparison of IDH mutation detection","volume":"112","author":"van den Bent","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5414\/NP300422","article-title":"IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS Research Committee","volume":"30","author":"Preusser","year":"2011","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib39","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jmoldx.2011.06.004","article-title":"Diagnostic testing for IDH1 and IDH2 variants in acute myeloid leukemia an algorithmic approach using high-resolution melting curve analysis","volume":"13","author":"Patel","year":"2011","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2353\/jmoldx.2010.090188","article-title":"Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications","volume":"12","author":"Tsiatis","year":"2010","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/path.4898","article-title":"TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma","volume":"242","author":"Schwartz","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jmoldx.2013.03.001","volume":"15","author":"Lindeman","year":"2013","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11899-015-0289-7","article-title":"Molecular pathogenesis of peripheral T cell lymphoma","volume":"10","author":"Sakata-Yanagimoto","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12185-015-1738-8","article-title":"Multistep tumorigenesis in peripheral T cell lymphoma","volume":"102","author":"Sakata-Yanagimoto","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib45","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1038\/bcj.2016.122","article-title":"Identification of cell-type-specific mutations in nodal T-cell lymphomas","volume":"7","author":"Nguyen","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib47","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/2159-8290.CD-16-1034","article-title":"AG-221, a first-in-class therapy targeting acute myeloid leukemia harboring oncogenic IDH2 mutations","volume":"7","author":"Yen","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood-2017-04-779447","article-title":"Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response","volume":"130","author":"Amatangelo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2018.05.012_bib49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1200\/JCO.2013.50.2047","article-title":"Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group","volume":"32","author":"Janin","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157817305354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157817305354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T07:51:08Z","timestamp":1576223468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157817305354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1525157817305354"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2018.05.012","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2018.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}